Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Cardiology
•
Structural Heart Disease
How do you decide the duration of DAPT following TAVR, especially for patients already on a DOAC?
Answer from: at Academic Institution
ASA mono Rx usually suffices after TAVR. If PCI + TAVR is performed, then triple Rx for 2-4 weeks, followed by Clopidogrel + DOAC therefore.
Sign In
or
Register
to read more
29859
Related Questions
In patients with moderate calcific mitral stenosis, possible HFpEF and dyspnea on exertion, how would you differentiate the etiology of the symptoms?
How should one approach management of a patient with asymptomatic severe primary (prolapse) TR and normal RV function (EF and strain) but with RA/RV enlargement?
In a patient with severe TR, when is the best time to start thinking about T-TEER?
How do you decide between opting for semi-elective outpatient versus inpatient TAVR for patients with severe critical AS?
Which anticoagulant (DOAC or Warfarin) would you recommend in the case of a 70-year-old male with persistent atrial fibrillation and history of rheumatic mitral stenosis now status post bioprosthetic MVR?
How would you approach the INR goal in a patient with mechanical aortic valve and high bleeding risk factors like immune thrombocytopenia, AV malformations and recurrent GI bleeds, etc.?
Would it be reasonable to consider combined BAV plus staged PCI in a patient presenting with ACS and new LV systolic dysfunction, moderate aortic stenosis, and complex bifurcating left main disease and RCA CTO?
Is there any role for routine CT TAVR a few months after TAVR to look for HALT?
Are there any indications for valve intervention in asymptomatic patients with moderate AS?
What would be your approach for the management of asymptomatic, severe AS with a peak velocity of 5 m/s in an otherwise physically active patient in their mid-90s without significant co-morbidities?